Released: April 19, 2013
DEPARTMENT OF DEFENSE LUNG CANCER RESEARCH PROGRAM
FISCAL YEAR 2013 STRATEGIC PLAN
The Fiscal Year 2013 (FY13) Defense Appropriations Act provides for $10.5 million to the Department of Defense Lung Cancer Research Program (LCRP) to support innovative, high-impact lung cancer research. This program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of the Congressionally Directed Medical Research Programs (CDMRP).
The LCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY13 LCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in May 2013. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.
Areas of Emphasis: The FY13 LCRP encourages research projects that specifically address the critical needs of the lung cancer community in the following Areas of Emphasis:
- Identification or development of noninvasive or minimally invasive tools to improve the detection of the initial stages of lung cancer.
- Identification, development, and/or building upon already existing tools for screening or early detection of lung cancer. Screening may include, but is not limited to, computed tomography scans, X-rays, other imaging biomarkers, genetics/genomics/proteomics/metabolomics, and assessment of risk factors.
- Understanding the molecular mechanisms of progression to clinically significant lung cancer.
- Understanding the molecular mechanisms that lead to various subtypes of lung cancer.
- Identification of innovative strategies for prevention and treatment of early lung cancer.
- Understanding predictive and prognostic markers to identify responders and nonresponders.
- Understanding susceptibility or resistance to treatment.
|Award Mechanism||Eligibility||Key Mechanism Elements||Funding|
|Concept Award||Investigators at all academic levels||
|Career Development Award||Principal Investigator: Independent investigators at the level of Assistant Professor, Instructor, or equivalent; must be within 5 years of first faculty appointment
Mentor: At or above the level of Associate Professor (or equivalent); have a proven publication and funding record in lung cancer research
|Clinical Exploration Award||Independent investigators at or above the level of Assistant Professor (or equivalent)||
|Idea Development Award||Established Investigators: Independent investigators at or above the level of Assistant Professor (or equivalent); or
New Investigators: Investigators that meet the following criteria at the application submission deadline date:
All applications must conform to the final program announcements and general application instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the program announcements are released. Requests for email notification of the program announcement release may be sent to email@example.com. For more information about the LCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
Point of Contact:
- CDMRP Public Affairs